5-Oxo-ETE and the OXE receptor

Prostaglandins and Other Lipid Mediators

Volumn 89, Issue 3-4, 2009, Pages 98-104

  Grant, Gail E ^a   Rokach, Joshua ^b   Powell, William S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Florida Institute of Technology   (United States)

Author keywords

5 Hydroxyeicosanoid dehydrogenase; 5 Oxo ETE; Asthma; Cancer; Eosinophils; HETEs; Inflammation; Leukotrienes; Neutrophils; OXE receptor; Polyunsaturated fatty acids; Structure activity relationships

Indexed keywords

5 OXO ETE; CHEMOATTRACTANT; HYDROXYEICOSANOID DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ALLERGY; APOPTOSIS; ASTHMA; BASOPHIL; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CELL SURVIVAL; CHEMICAL STRUCTURE; ENZYME SYNTHESIS; EOSINOPHIL; HUMAN; MOLECULAR CLONING; MONOCYTE; NEOPLASM; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTE; REVIEW; TUMOR CELL;

ALCOHOL OXIDOREDUCTASES; ANIMALS; ARACHIDONIC ACIDS; ASTHMA; CARDIOVASCULAR DISEASES; CELL SURVIVAL; CHEMOTACTIC FACTORS; HUMANS; LIGANDS; NEOPLASMS; OXIDATIVE STRESS; RECEPTORS, EICOSANOID; SIGNAL TRANSDUCTION;

EID: 69549130721     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2009.05.002     Document Type: Review

References (87)

1. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
2. 4, platelet-activating factor, and 5-HETE. J Cell Physiol 122 (1985) 229-239
3. O'Flaherty J.T., Jacobson D., and Redman J. Mechanism involved in the mobilization of neutrophil calcium by 5-hydroxyeicosatetraenoate. J Immunol 140 (1988) 4323-4328
4. O'Flaherty J.T., and Nishihira J. 5-Hydroxyeicosatetraenoate promotes Ca2+ and protein kinase C mobilization in neutrophils. Biochem Biophys Res Commun 148 (1987) 575-581
5. Powell W.S., Gravelle F., and Gravel S. Metabolism of 5(S)-hydroxy-6,8,11,14-eicosatetraenoic acid and other 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes. J Biol Chem 267 (1992) 19233-19241
6. 4 receptor. J Biol Chem 268 (1993) 9280-9286
7. Powell W.S., and Rokach J. Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE. Prog Lipid Res 44 (2005) 154-183
8. Patel P., Cossette C., Anumolu J.R., et al. Substrate selectivity of 5-hydroxyeicosanoid dehydrogenase and its inhibition by 5-hydroxy-delta(6)-long-chain fatty acids. J Pharmacol Exp Ther 329 (2009) 335-341
9. Cossette C., Patel P., Anumolu J.R., et al. Human neutrophils convert the sebum-derived polyunsaturated fatty acid sebaleic acid to a potent granulocyte chemoattractant. J Biol Chem 283 (2008) 11234-11243
10. Patel P., Cossette C., Anumolu J.R., et al. Structural requirements for activation of the 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity. J Pharmacol Exp Ther 325 (2008) 698-707
11. 4 hydrolase. J Biol Chem 260 (1985) 10966-10970
12. Powell W.S., Gravel S., and Gravelle F. Formation of a 5-oxo metabolite of 5,8,11,14, 17-eicosapentaenoic acid and its effects on human neutrophils and eosinophils. J Lipid Res 36 (1995) 2590-2598
13. Zhang Y., Styhler A., and Powell W.S. Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid by human monocytes and lymphocytes. J Leukoc Biol 59 (1996) 847-854
14. Zimpfer U., Dichmann S., Termeer C.C., Simon J.C., Schröder J.M., Norgauer J., et al. Human dendritic cells are a physiological source of the chemotactic arachidonic acid metabolite 5-oxo-eicosatetraenoic acid. Inflamm Res 49 (2000) 633-638
15. Powell W.S., Gravel S., Khanapure S.P., and Rokach J. Biological inactivation of 5-oxo-6,8,11,14-eicosatetraenoic acid by human platelets. Blood 93 (1999) 1086-1096
16. Erlemann K.R., Cossette C., Gravel S., et al. Metabolism of 5-hydroxy-6,8,11,14-eicosatetraenoic acid by human endothelial cells. Biochem Biophys Res Commun 350 (2006) 151-156
17. Erlemann K.R., Erlemann K.R., Cossette C., Gravel S., et al. Airway epithelial cells synthesize the lipid mediator 5-oxo-ETE in response to oxidative stress. Free Radic Biol Med 42 (2007) 654-664
18. Folco G., and Murphy R.C. Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacol Rev 58 (2006) 375-388
19. Erlemann K.R., Cossette C., Grant G.E., et al. Regulation of 5-hydroxyeicosanoid dehydrogenase activity in monocytic cells. Biochem J 403 (2007) 157-165
20. O'Flaherty J.T., Wykle R., Redman J., Samuel M., and Thomas M. Metabolism of 5-hydroxyicosatetraenoate by human neutrophils: production of a novel omega-oxidized derivative. J Immunol 137 (1986) 3277-3283
21. Powell W.S., MacLeod R.J., Gravel S., Gravelle F., and Bhakar A. Metabolism and biologic effects of 5-oxoeicosanoids on human neutrophils. J Immunol 156 (1996) 336-342
22. Powell W.S., Gravelle F., and Gravel S. Phorbol myristate acetate stimulates the formation of 5-oxo-6,8,11,14-eicosatetraenoic acid by human neutrophils by activating NADPH oxidase. J Biol Chem 269 (1994) 25373-25380
23. Graham F.D., Erlemann K.R., Gravel S., Rokach J., and Powell W.S. Oxidative stress-induced changes in pyridine nucleotides and chemoattractant 5-lipoxygenase products in aging neutrophils. Free Radic Biol Med 47 (2009) 62-71
24. Erlemann K.R., Rokach J., and Powell W.S. Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid by inflammatory cells. J Biol Chem 279 (2004) 40376-40384
25. Berhane K., Ray A.A., Khanapure S.P., Rokach J., and Powell W.S. Calcium/calmodulin-dependent conversion of 5-oxoeicosanoids to 6,7-dihydro metabolites by a cytosolic olefin reductase in human neutrophils. J Biol Chem 273 (1998) 20951-20959
26. Hevko J.M., Bowers R.C., and Murphy R.C. Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid and identification of novel omega-oxidized metabolites in the mouse macrophage. J Pharmacol Exp Ther 296 (2001) 293-305
27. 7) chemotactic for human granulocytes. J Biol Chem 275 (2000) 29931-29934
28. 4 synthase. J Biol Chem 277 (2002) 7037-7043
29. Schwenk U., and Schröder J.M. 5-Oxo-eicosanoids are potent eosinophil chemotactic factors-functional characterization and structural requirements. J Biol Chem 270 (1995) 15029-15036
30. O'Flaherty J.T., Taylor J.S., and Thomas M.J. Receptors for the 5-oxo class of eicosanoids in neutrophils. J Biol Chem 273 (1998) 32535-32541
31. O'Flaherty J.T., Cordes J., Redman J., and Thomas M.J. 5-Oxo-eicosatetraenoate, a potent human neutrophil stimulus. Biochem Biophys Res Commun 192 (1993) 129-134
32. Powell W.S., Gravel S., Halwani F., et al. Effects of 5-oxo-6,8,11,14-eicosatetraenoic acid on expression of CD11b, actin polymerization and adherence in human neutrophils. J Immunol 159 (1997) 2952-2959
33. i/o. J Biol Chem 277 (2002) 31459-31465
34. Jones C.E., Holden S., Tenaillon L., et al. Expression and characterization of a 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophils. Mol Pharmacol 63 (2003) 471-477
35. Takeda S., Yamamoto A., and Haga T. Identification of a G protein-coupled receptor for 5-oxo-eicosatetraenoic acid. Biomed Res Tokyo 23 (2002) 101-108
36. Brink C., Dahlén S.E., Drazen J., et al. International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor. Pharmacol Rev 56 (2004) 149-157
37. 2+ transients, actin reorganization, superoxide-anion production and receptor up-regulation. Eur J Biochem 236 (1996) 1003-1009
38. O'Flaherty J.T., Kuroki M., Nixon A.B., et al. 5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway. J Biol Chem 271 (1996) 17821-17828
39. Hosoi T., Sugikawa E., Chikada A., Koguchi Y., and Ohnuki T. TG1019/OXE, a Galpha(i/o)-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis. Biochem Biophys Res Commun 334 (2005) 987-995
40. O'Flaherty J.T., Rogers L.C., Chadwell B.A., et al. 5(S)-hydroxy-6,8,11,14-E,Z,Z,Z-eicosatetraenoate stimulates PC3 cell signaling and growth by a receptor-dependent mechanism. Cancer Res 62 (2002) 6817-6819
41. Langlois A., Chouinard F., Flamand N., et al. Crucial implication of protein kinase C (PKC)-delta, PKC-zeta, ERK-1/2, and p38 MAPK in migration of human asthmatic eosinophils. J Leukoc Biol 85 (2009) 656-663
42. O'Flaherty J.T., Kuroki M., Nixon A.B., et al. 5-Oxo-eicosatetraenoate is a broadly active, eosinophil-selective stimulus for human granulocytes. J Immunol 157 (1996) 336-342
43. Lin L.L., Wartmann M., Lin A.Y., et al. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72 (1993) 269-278
44. O'Flaherty J.T., Cordes J.F., Lee S.L., Samuel M., and Thomas M.J. Chemical and biological characterization of oxo-eicosatetraenoic acids. Biochim Biophys Acta 1201 (1994) 505-515
45. Sundaram S., and Ghosh J. Expression of 5-oxoETE receptor in prostate cancer cells: critical role in survival. Biochem Biophys Res Commun 339 (2006) 93-98
46. Ghosh J., and Myers C.E. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA 95 (1998) 13182-13187
47. Sturm G.J., Schuligoi R., Sturm E.M., et al. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent chemoattractant for human basophils. J Allergy Clin Immunol 116 (2005) 1014-1019
48. Powell W.S., Chung D., and Gravel S. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. J Immunol 154 (1995) 4123-4132
49. Flood-Page P., Menzies-Gow A., Phipps S., et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112 (2003) 1029-1036
50. Peters-Golden M., and Henderson Jr. W.R. Leukotrienes. N Engl J Med 357 (2007) 1841-1854
51. Rådinger M., and Lötvall J. Eosinophil progenitors in allergy and asthma-do they matter?. Pharmacol Ther 121 (2009) 174-184
52. Leckie M.J., ten Brinke A., Khan J., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356 (2000) 2144-2148
53. Flood-Page P.T., Menzies-Gow A.N., Kay A.B., and Robinson D.S. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167 (2003) 199-204
54. Jacobsen E.A., Ochkur S.I., Lee N.A., and Lee J.J. Eosinophils and asthma. Curr Allergy Asthma Rep 7 (2007) 18-26
55. Powell W.S., Ahmed S., Gravel S., and Rokach J. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis. J Allergy Clin Immunol 107 (2001) 272-278
56. Guilbert M., Ferland C., Bosse M., et al. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils. Am J Respir Cell Mol Biol 21 (1999) 97-104
57. Dallaire M.J., Ferland C., Page N., et al. Endothelial cells modulate eosinophil surface markers and mediator release. Eur Respir J 21 (2003) 918-924
58. Powell W.S., Gravel S., and Halwani F. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of l-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils. Am J Respir Cell Mol Biol 20 (1999) 163-170
59. Muro S., Hamid Q., Olivenstein R., et al. 5-oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin. J Allergy Clin Immunol 112 (2003) 768-774
60. Stamatiou P.B., Chan C.C., Monneret G., et al. 5-Oxo-6,8,11,14-eicosatetraenoic acid stimulates the release of the eosinophil survival factor granulocyte-macrophage colony stimulating factor from monocytes. J Biol Chem 279 (2004) 28159-28164
61. Park C.S., Choi Y.S., Ki S.Y., et al. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. Eur Respir J 12 (1998) 872-878
62. 4 synthesis. J Immunol 140 (1988) 4315-4322
63. Pouliot M., McDonald P.P., Khamzina L., Borgeat P., and McColl S.R. Granulocyte-macrophage colony-stimulating factor enhances 5-lipoxygenase levels in human polymorphonuclear leukocytes. J Immunol 152 (1994) 851-858
64. Pouliot M., McDonald P.P., Borgeat P., and McColl S.R. Granulocyte macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J Exp Med 179 (1994) 1225-1232
65. Gibbs B.F. Human basophils as effectors and immunomodulators of allergic inflammation and innate immunity. Clin Exp Med 5 (2005) 43-49
66. 2 and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils. J Pharmacol Exp Ther 312 (2005) 627-634
67. 4 induces degranulation. J Allergy Clin Immunol 116 (2005) 578-585
68. Suzukawa M., Komiya A., Iikura M., et al. Trans-basement membrane migration of human basophils: role of matrix metalloproteinase-9. Int Immunol 18 (2006) 1575-1583
69. 6-long chain fatty acids. J Pharmacol Exp Ther 329 (2009) 335-341
70. Zarini S., and Murphy R.C. Biosynthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid from 5-hydroperoxyeicosatetraenoic acid in the murine macrophage. J Biol Chem 278 (2003) 11190-11196
71. Rose D.P., and Connolly J.M. Dietary fat, fatty acids and prostate cancer. Lipids 27 (1992) 798-803
72. Ghosh J., and Myers C.E. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 235 (1997) 418-423
73. Gupta S., Srivastava M., Ahmad N., et al. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer 91 (2001) 737-743
74. Rioux N., and Castonguay A. Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis 19 (1998) 1393-1400
75. Moody T.W., Leyton J., Martinez A., et al. Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. Exp Lung Res 24 (1998) 617-628
76. Avis I., Hong S.H., Martinez A., et al. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 15 (2001) 2007-2009
77. Hammamieh R., Sumaida D., Zhang X., Das R., and Jett M. Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism. BMC Cancer 7 (2007) 138
78. Edderkaoui M., Hong P., Vaquero E.C., et al. Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. Am J Physiol Gastrointest Liver Physiol 289 (2005) G1137-G1147
79. Datta K., Biswal S.S., and Kehrer J.P. The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP. Biochem J 340 (1999) 371-375
80. Ghosh J. Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun 315 (2004) 624-635
81. O'Flaherty J.T., Rogers L.C., Paumi C.M., et al. 5-Oxo-ETE analogs and the proliferation of cancer cells. Biochim Biophys Acta 1736 (2005) 228-236
82. Hassan S., and Carraway R.E. Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth. Regul Pept 133 (2006) 105-114
83. Cormier S.A., Taranova A.G., Bedient C., et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 79 (2006) 1131-1139
84. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36 (2004) 233-239
85. Mestas J., and Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 18 (2008) 228-232
86. Hoogeveen R.C., Morrison A., Boerwinkle E., et al. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: atherosclerosis risk in communities study. Atherosclerosis 183 (2005) 301-307
87. 4. J Immunol 150 (1993) 206-213